P R Tiller, J Cunniff, A P Land, J Schwartz, I Jardine, M Wakefield, L Lopez, J F Newton, R D Burton, B M Folk, D L Buhrman, P Price, D Wu
Index: J. Chromatogr. A. 771(1-2) , 119-25, (1997)
Full Text: HTML
The specificity and selectivity of LC-MS-MS is illustrated to explain why LC-MS-MS has become the method of choice for quantitation within the pharmaceutical industry. Two assays are described that demonstrate the facility with which new ion trap technology can utilize the selectivity and sensitivity of LC-MS-MS to quantitate trace level components within complex matrices, in particular human plasma. One assay undergoes a validation procedure and demonstrates the utility of this new technology for drug quantitation within a regulated environment.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Foropafant
CAS:136468-36-5 |
C28H40N4S |
|
Platelet-activating factor (PAF) is not an essential compone...
1995-07-01 [J. Lipid Mediat. Cell Signal. 12(1) , 49-57, (1995)] |
|
Prevention of platelet-activating factor-induced gastrointes...
1996-04-01 [Arzneimittelforschung 46(4) , 407-12, (1996)] |
|
Role of platelet activating factor in the intestinal epithel...
1994-09-27 [Proc. Natl. Acad. Sci. U. S. A. 91(20) , 9655-8, (1994)] |
|
Effect of SR 27417, a novel PAF antagonist on antigen-induce...
1997-01-01 [J. Lipid Mediat. Cell Signal. 15(2) , 115-23, (1997)] |
|
Putative effect of Helicobacter pylori and gastritis on gast...
2002-04-01 [Am. J. Physiol. Gastrointest. Liver Physiol. 282(4) , G727-34, (2002)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
